Ekso Bionics Holdings Inc
NASDAQ:EKSO
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Price:
1.08 USD
-1.82%
Market Closed
Updated:
Jun 10, 2024
Ekso Bionics Holdings Inc
Accrued Liabilities
|
Ekso Bionics Holdings Inc
Accrued Liabilities Peer Comparison
Comparables:
BSX
SYK
ABT
ISRG
SWAV
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
Accrued Liabilities
$2.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$6.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$691.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Accrued Liabilities
$73m
|
CAGR 3-Years
43%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
See Also
What is Ekso Bionics Holdings Inc's Accrued Liabilities?
Accrued Liabilities
2.2m
USD
2.2m
USD
Based on the financial report for Mar 31, 2024, Ekso Bionics Holdings Inc's Accrued Liabilities amounts to 2.2m USD.
What is Ekso Bionics Holdings Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-9%
-9%
Over the last year, the Accrued Liabilities growth was -16%. The average annual Accrued Liabilities growth rates for Ekso Bionics Holdings Inc have been 2% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
